The integration of molecular and clinical information to tailor treatments remains an important research challenge in chronic lymphocytic leukaemia (CLL). This study aimed to identify genomic lesions associated with a poor outcome and a higher risk of histological transformation. A mono-institutional cohort of 147 cases was used as the test series, and a multi-institutional cohort of 176 cases as a validation series. Genomic profiles were obtained using Affymetrix SNP 6.0. The impact of the recurrent minimal common regions (MCRs) on overall survival was evaluated by univariate analysis followed by multiple-test correction. The independent prognostic significance was assessed by multivariate analysis. Eight MCRs showed a prognostic impact: gains at 2p25.3-p22.3 (MYCN), 2p22.3, 2p16.2-p14 (REL), 8q23.3-q24.3 (MYC), losses at 8p23.1-p21.2, 8p21.2, and of the TP53 locus. Gains at 2p and 8q and TP53 inactivation maintained prognostic significance in multivariate analysis and a hierarchical model confirmed their relevance. Gains at 2p also determined a higher risk of Richter syndrome transformation. The prediction of outcome for CLL patients might be improved by evaluating the presence of gains at 2p and 8q as novel genomic regions besides those included in the 'standard' fluorescence in situ hybridization panel.

Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia / Rinaldi, A; Mian, M; Kwee, I; Rossi, D; Deambrogi, C; Mensah, Aa; Forconi, F; Spina, V; Cencini, E; Drandi, D; Ladetto, M; Santachiara, Rita; Marasca, Roberto; Gattei, V; Cavalli, F; Zucca, E; Gaidano, G; Bertoni, F.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - STAMPA. - 154:5(2011), pp. 590-599. [10.1111/j.1365-2141.2011.08789.x]

Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia

SANTACHIARA, Rita;MARASCA, Roberto;
2011

Abstract

The integration of molecular and clinical information to tailor treatments remains an important research challenge in chronic lymphocytic leukaemia (CLL). This study aimed to identify genomic lesions associated with a poor outcome and a higher risk of histological transformation. A mono-institutional cohort of 147 cases was used as the test series, and a multi-institutional cohort of 176 cases as a validation series. Genomic profiles were obtained using Affymetrix SNP 6.0. The impact of the recurrent minimal common regions (MCRs) on overall survival was evaluated by univariate analysis followed by multiple-test correction. The independent prognostic significance was assessed by multivariate analysis. Eight MCRs showed a prognostic impact: gains at 2p25.3-p22.3 (MYCN), 2p22.3, 2p16.2-p14 (REL), 8q23.3-q24.3 (MYC), losses at 8p23.1-p21.2, 8p21.2, and of the TP53 locus. Gains at 2p and 8q and TP53 inactivation maintained prognostic significance in multivariate analysis and a hierarchical model confirmed their relevance. Gains at 2p also determined a higher risk of Richter syndrome transformation. The prediction of outcome for CLL patients might be improved by evaluating the presence of gains at 2p and 8q as novel genomic regions besides those included in the 'standard' fluorescence in situ hybridization panel.
2011
154
5
590
599
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia / Rinaldi, A; Mian, M; Kwee, I; Rossi, D; Deambrogi, C; Mensah, Aa; Forconi, F; Spina, V; Cencini, E; Drandi, D; Ladetto, M; Santachiara, Rita; Marasca, Roberto; Gattei, V; Cavalli, F; Zucca, E; Gaidano, G; Bertoni, F.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - STAMPA. - 154:5(2011), pp. 590-599. [10.1111/j.1365-2141.2011.08789.x]
Rinaldi, A; Mian, M; Kwee, I; Rossi, D; Deambrogi, C; Mensah, Aa; Forconi, F; Spina, V; Cencini, E; Drandi, D; Ladetto, M; Santachiara, Rita; Marasca,...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/695081
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 39
social impact